Researchers at the CPC-M site of the German Center for Lung Research (DZL), together with partner institutions, have published a new study presenting a promising therapeutic strategy for allergic asthma.
Why do some people with asthma experience severe flare-ups after viral infections, while others show hardly any symptoms? DZL researchers have uncovered an underlying mechanism and identified a biomarker that could help predict severe exacerbations...
Despite their enormous disease burden, respiratory illnesses such as COPD and asthma receive little attention in research, policy, and public discourse. An international group of early career scientists is now calling for greater visibility, national...
Repeated infections with rhinoviruses can induce epigenetic changes in the human bronchial epithelium. Researchers from the German Center for Lung Research (DZL) have now demonstrated for the first time that structural airway cells can develop...
A research team at DZL site CPC-M is developing an innovative RNA-based inhalation therapy for lung diseases. The project is supported by a €2.5 million grant from the European Innovation Council.
Why do children who grow up on farms develop asthma and allergies less frequently? Researchers at the Dr. von Hauner Children's Hospital of the LMU Klinikum have made a significant step toward understanding how this...
The international consortium RESPIRE-EXCEL has received 3.3 million euros from the EU’s Horizon Europe programme: Scientists from the DZL sites ARCN and CPC-M are among those to receive funding.
“Yes, we care” - this was the motto of an online information event of the ALLIANCE asthma study. More than 70 people, many of them study participants their family members, joined in. All ALLIANCE study...
Researchers have analyzed the messenger molecule IL-33 in the airways of asthma and COPD patients. The findings suggest that former smokers, in particular, could benefit from potential therapies targeting IL-33.
A new approach to better predict childhood asthma involves combining molecular markers, epidemiological factors, and allergic symptoms.
The first issue of SYNERGIE this year focuses on all external influences on the body. The DZL article deals with whether diseases can be diagnosed using exhaled air.
Dr Ruth Grychtol is researching individualised asthma therapy for children and adolescents. For her work, she received the Johannes Wenner Research Prize, worth 15,000 euros.
